Skip to main content

Advertisement

Log in

Vascular calcification and osteoporosis—from clinical observation towards molecular understanding

Osteoporosis International Aims and scope Submit manuscript

Abstract

Patients with osteoporosis frequently suffer from vascular calcification, which was shown to predict both cardiovascular morbidity/mortality and osteoporotic fractures. Various common risk factors and mechanisms have been suggested to cause both bone loss and vascular calcification, including aging, estrogen deficiency, vitamin D and K abnormalities, chronic inflammation and oxidative stress. Major breakthroughs in molecular and cellular biology of bone metabolism and the characterization of knockout animals with deletion of bone-related genes have led to the concept that common signaling pathways, transcription factors and extracellular matrix interactions may account for both skeletal and vascular abnormalities. For example, mice that lack the cytokine decoy receptor osteoprotegerin or the hormone Klotho display a combined osteoporosis-arterial calcification phenotype. In this review, we summarize the current data and evaluate potential mechanisms of the osteoporosis-arterial calcification syndrome. We propose a unifying hypothesis of vascular calcification that combines both active and passive mechanisms of vascular mineralization with aspects of bone resorption and age-related changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification over a 25-year period: the Framingham heart study. Calcif Tissue Int 68:271–276. Erratum in: Calcif Tissue Int (2004) 74:208

    Article  PubMed  CAS  Google Scholar 

  2. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V (2004) Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246–4253

    Article  PubMed  CAS  Google Scholar 

  3. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C, Prospective Epidemiological Risk Factors Study Group (2006) Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259:598–605

    Article  PubMed  CAS  Google Scholar 

  4. Tanko LB, Bagger YZ, Christiansen C (2003) Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73:15–20

    Article  PubMed  CAS  Google Scholar 

  5. Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15:389–395

    Article  PubMed  CAS  Google Scholar 

  6. Demer LL (2002) Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol 31:737–741

    Article  PubMed  Google Scholar 

  7. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760

    PubMed  CAS  Google Scholar 

  8. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680–687

    PubMed  CAS  Google Scholar 

  9. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE (1996) Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int 59:352–356

    Article  PubMed  CAS  Google Scholar 

  10. Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, Shah PK, Rajavashisth TB (2004) Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev 25:629–672

    Article  PubMed  CAS  Google Scholar 

  11. Shanahan CM (2005) Mechanisms of vascular calcification in renal disease. Clin Nephrol 63:146–157

    PubMed  CAS  Google Scholar 

  12. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393–2402

    Article  PubMed  CAS  Google Scholar 

  13. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45–51

    Article  PubMed  CAS  Google Scholar 

  14. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260–1268

    Article  PubMed  CAS  Google Scholar 

  15. Thompson GR, Partridge J (2004) Coronary calcification score: the coronary-risk impact factor. Lancet 363:557–559

    Article  PubMed  CAS  Google Scholar 

  16. Schaefer S (2002) Will helical CT replace electron beam CT in the assessment of coronary calcium? Prev Cardiol 5:84–86

    Article  PubMed  Google Scholar 

  17. Stanford W, Thompson BH, Burns TL, Heery SD, Burr MC (2004) Coronary artery calcium quantification at multi-detector row helical CT versus electron-beam CT. Radiology 230:397–402

    Article  PubMed  Google Scholar 

  18. Schousboe JT, Wilson KE, Kiel DP (2006) Detection of abdominal aortic calcification with lateral spine imaging using DXA. J Clin Densitom 9:302–308

    Article  PubMed  Google Scholar 

  19. Eisman JA (1999) Genetics of osteoporosis. Endocr Rev 20:788–804

    Article  PubMed  CAS  Google Scholar 

  20. Kawano K, Ogata N, Chiano M, Molloy H, Kleyn P, Spector TD, Uchida M, Hosoi T, Suzuki T, Orimo H, Inoue S, Nabeshima Y, Nakamura K, Kuro-o M, Kawaguchi H (2002) Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Miner Res 17:1744–1751

    Article  PubMed  CAS  Google Scholar 

  21. Imamura A, Okumura K, Ogawa Y, Murakami R, Torigoe M, Numaguchi Y, Murohara T (2006) Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese. Clin Chim Acta 371:66–70

    Article  PubMed  CAS  Google Scholar 

  22. Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 17:1245–1255

    Article  PubMed  CAS  Google Scholar 

  23. Soufi M, Schoppet M, Sattler AM, Herzum M, Maisch B, Hofbauer LC, Schaefer JR (2004) Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab 89:3764–3768

    Article  PubMed  CAS  Google Scholar 

  24. Brandstrom H, Stiger F, Lind L, Kahan T, Melhus H, Kindmark A (2002) A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. Biochem Biophys Res Commun 293:13–17

    Article  PubMed  CAS  Google Scholar 

  25. Taylor BC, Schreiner PJ, Doherty TM, Fornage M, Carr JJ, Sidney S (2005) Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the CARDIA study. Hum Genet 116:525–528

    Article  PubMed  CAS  Google Scholar 

  26. Osawa M, Tian W, Horiuchi H, Kaneko M, Umetsu K (2005) Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels. Hum Genet 116:146–151

    Article  PubMed  CAS  Google Scholar 

  27. Ross R (2004) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115–126

    Article  Google Scholar 

  28. Hofbauer LC, Schrader J, Niebergall U, Viereck V, Burchert A, Hörsch D, Preissner KT, Schoppet M (2006) Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells. Thromb Haemost 95:708–714

    PubMed  CAS  Google Scholar 

  29. Abedin M, Tintut Y, Demer LL (2004) Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24:1161–1170

    Article  PubMed  CAS  Google Scholar 

  30. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, Demer LL (2003) Multilineage potential of cells from the artery wall. Circulation 108:2505–2510

    Article  PubMed  Google Scholar 

  31. Schinke T, Karsenty G (2000) Vascular calcification-a passive process in need of inhibitors. Nephrol Dial Transplant 15:1272–1274

    Article  PubMed  CAS  Google Scholar 

  32. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Hohne W, Schauer G, Lehmann M, Roscioli T, Schnabel D, Epplen JT, Knisely A, Superti-Furga A, McGill J, Filippone M, Sinaiko AR, Vallance H, Hinrichs B, Smith W, Ferre M, Terkeltaub R, Nurnberg P (2003) Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet 34:379–381

    Article  PubMed  CAS  Google Scholar 

  33. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78–81

    Article  PubMed  CAS  Google Scholar 

  34. Gerstenfeld LC (1999) Osteopontin in skeletal tissue homeostasis: an emerging picture of the autocrine/paracrine functions of the extracellular matrix. J Bone Miner Res 14:850–855

    Article  PubMed  CAS  Google Scholar 

  35. Gravallese EM (2003) Osteopontin: a bridge between bone and the immune system. J Clin Invest 112:147–149. Erratum in: J Clin Invest (2003) 112:627

    PubMed  CAS  Google Scholar 

  36. Denhardt DT, Noda M, O’Regan AW, Pavlin D, Berman JS (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107:1055–1061

    Article  PubMed  CAS  Google Scholar 

  37. Khan SA, Lopez-Chua CA, Zhang J, Fisher LW, Sorensen ES, Denhardt DT (2002) Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors. J Cell Biochem 85:728–736

    Article  PubMed  CAS  Google Scholar 

  38. Pritzker LB, Scatena M, Giachelli CM (2004) The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. Mol Biol Cell 15:2834–2841

    Article  PubMed  CAS  Google Scholar 

  39. Yoshitake H, Rittling SR, Denhardt DT, Noda M (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:8156–8160. Erratum in: Proc Natl Acad Sci USA 96:10944

    Article  PubMed  CAS  Google Scholar 

  40. Ishijima M, Tsuji K, Rittling SR, Yamashita T, Kurosawa H, Denhardt DT, Nifuji A, Noda M (2002) Resistance to unloading-induced three-dimensional bone loss in osteopontin-deficient mice. J Bone Miner Res 4:661–667. Erratum in: J Bone Miner Res (2003) 18:1558

    Article  Google Scholar 

  41. Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M (2002) Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA 99:4556–4561

    Article  PubMed  CAS  Google Scholar 

  42. Nemoto H, Rittling SR, Yoshitake H, Furuya K, Amagasa T, Tsuji K, Nifuji A, Denhardt DT, Noda M (2001) Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissue. J Bone Miner Res 16:652–659

    Article  PubMed  CAS  Google Scholar 

  43. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT (1994) Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 94:1597–1604

    Article  PubMed  CAS  Google Scholar 

  44. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, Tung E, Karsenty G, Giachelli CM (2002) Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196:1047–1055

    Article  PubMed  CAS  Google Scholar 

  45. Heiss A, DuChesne A, Denecke B, Grotzinger J, Yamamoto K, Renne T, Jahnen-Dechent W (2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278:13333–13341

    Article  PubMed  CAS  Google Scholar 

  46. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827–833

    Article  PubMed  CAS  Google Scholar 

  47. Schäfer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent WJ (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366

    PubMed  Google Scholar 

  48. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685–700

    Article  PubMed  CAS  Google Scholar 

  49. Hruska KA, Mathew S, Saab G (2005) Bone morphogenetic proteins in vascular calcification. Circ Res 97:105–114

    Article  PubMed  CAS  Google Scholar 

  50. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone MA Jr, Falb D, Huszar D (2000) A role for smad6 in development and homeostasis of the cardiovascular system. Nature Genetics 24:171–174

    Article  PubMed  CAS  Google Scholar 

  51. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M (2005) Suppression of aging in mice by the hormone Klotho. Science 309:1829–1833

    Article  PubMed  CAS  Google Scholar 

  52. Ikushima M, Rakugi H, Ishikawa K, Maekawa Y, Yamamoto K, Ohta J, Chihara Y, Kida I, Ogihara T (2005) Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem Biophys Res Commun 339:827–832

    Article  PubMed  CAS  Google Scholar 

  53. Nagai T, Yamada K, Kim HC, Kim YS, Noda Y, Imura A, Nabeshima Y, NabeshimaT (2003) Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J 17:50–52

    PubMed  CAS  Google Scholar 

  54. Shimada T, Takeshita Y, Murohara T, Sasaki K, Egami K, Shintani S, KatsudaY, Ikeda H, Nabeshima Y, Imaizumi T (2004) Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 110:1148–1155

    Article  PubMed  Google Scholar 

  55. Kawaguchi H, Manabe N, Miyaura C, Chikuda H, Nakamura K, Kuro-o M (1999) Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. J Clin Invest 104:229–237

    Article  PubMed  CAS  Google Scholar 

  56. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325

    Article  PubMed  CAS  Google Scholar 

  57. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC, Young PR (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273:14363–14367

    Article  PubMed  CAS  Google Scholar 

  58. Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S, Van G, Kaufman S, Kostenuik PJ, Lacey DL, Boyle WJ, Simonet WS (2000) Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 192:463–474

    Article  PubMed  CAS  Google Scholar 

  59. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Eliott R, Colombero A, Tan H-L, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ, Amgen EST Program (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:159–161

    Article  Google Scholar 

  60. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315–323

    Article  PubMed  CAS  Google Scholar 

  61. Price PA, June HH, Buckley JR, Williamson MK (2001) Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21:1610–1616

    Article  PubMed  CAS  Google Scholar 

  62. Price PA, June HH, Buckley JR, Williamson MK (2002) SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat. Circ Res 91:547–552

    Article  PubMed  CAS  Google Scholar 

  63. Price PA, Faus SA, Williamson MK (2001) Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21:817–824

    Article  PubMed  CAS  Google Scholar 

  64. Tanko LB, Qin G, Alexandersen P, Bagger YZ, Christiansen C (2005) Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women. Osteoporos Int 16:184–190

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Research is supported by grants from Deutsche Forschungsgemeinschaft Ho 1875/3-1 and Ho 1875/3-2 to Dr. Hofbauer, Ho 1875/5-2 to Dr. Hofbauer and Dr. Schoppet, and fellowship grants from ESCEO-Amgen to Dr. Brück and Professor A. Schmidtmann-Foundation to Dr. Schoppet.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. C. Hofbauer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hofbauer, L.C., Brueck, C.C., Shanahan, C.M. et al. Vascular calcification and osteoporosis—from clinical observation towards molecular understanding. Osteoporos Int 18, 251–259 (2007). https://doi.org/10.1007/s00198-006-0282-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-006-0282-z

Keywords

Navigation